
UCSF Scientists Develop New CAR-T Therapy for Glioma
The engineered B-SYNC cells remain dormant until reaching the brain to improve safety and efficacy.
Live Poll
Should medical research prioritize funding for breakthrough treatments for rare, lethal childhood diseases?
